Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery

被引：53

作者：

Amolins, M. W. ^{[1
]}

Blagg, B. S. J. ^{[1
]}

机构：

[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2009年 / 9卷 / 02期

关键词：

Hsp90; inhibitors; cancer; neurodegenerative diseases; natural products; HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; IMPORTANT BIOLOGIC ACTIVITIES; ESCHERICHIA-COLI HSP90; MOLECULAR CHAPERONE; GELDANAMYCIN DERIVATIVES; CRYSTAL-STRUCTURE; ATP-BINDING; DNA GYRASE; ANTITUMOR-ACTIVITY;

D O I：

10.2174/138955709787316056

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Heat shock protein 90 has emerged as a promising target for the treatment of cancer and neurodegenerative diseases. This review summarizes recent advancements towards the development of natural products as they pertain to the biological and chemical understanding of this molecular chaperone.

引用

收藏

页码：140 / 152

页数：13

相关论文

共 173 条

[11] Solution- and solid-phase synthesis of radicicol (monorden) and pochonin C [J].

Barluenga, S ;

Moulin, E ;

Lopez, P ;

Winssinger, N .

CHEMISTRY-A EUROPEAN JOURNAL, 2005, 11 (17) :4935-4952

[12] Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function [J].

Basso, AD ;

Solit, DB ;

Chiosis, G ;

Giri, B ;

Tsichlis, P ;

Rosen, N .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39858-39866

[13]

Beltz Lisa Ann, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P389

[14] Preparation of 8-(arylsulfanyl)adenines with diazonium salts under mild, aerobic conditions [J].

Biamonte, MA ;

Shi, JD ;

Hurst, D ;

Hong, K ;

Boehm, MF ;

Kasibhatla, SR .

JOURNAL OF ORGANIC CHEMISTRY, 2005, 70 (02) :717-720

[15] Hsp90: A novel target for the disruption of multiple signaling cascades [J].

Bishop, Stephanie C. ;

Burlison, Joseph A. ;

Blagg, Brian S. J. .

CURRENT CANCER DRUG TARGETS, 2007, 7 (04) :369-388

[16] Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation [J].

Blagg, BSJ ;

Kerr, TA .

MEDICINAL RESEARCH REVIEWS, 2006, 26 (03) :310-338

[17] Gedunin, a Novel Hsp90 inhibitor: Semisynthesis of Derivatives and Preliminary Structure-Activity Relationships [J].

Brandt, Gary E. L. ;

Schmidt, Matthew D. ;

Prisinzano, Thomas E. ;

Blagg, Brian S. J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) :6495-6502

[18] Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines [J].

Burlison, Joseph A. ;

Avila, Christopher ;

Vielhauer, George ;

Lubbers, Donna J. ;

Holzbeierlein, Jeffrey ;

Blagg, Brian S. J. .

JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (06) :2130-2137

[19] Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery [J].

Burlison, Joseph A. ;

Blagg, Brian S. J. .

ORGANIC LETTERS, 2006, 8 (21) :4855-4858

[20] Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90 [J].

Burlison, Joseph A. ;

Neckers, Len ;

Smith, Andrew B. ;

Maxwell, Anthony ;

Blagg, Brian S. J. .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (48) :15529-15536

← 1 2 3 4 5 6 7 8 9 10 →